These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1551280)
21. Ascorbic acid does not improve endothelium-dependent flow-mediated dilatation of the brachial artery in patients with Raynaud's phenomenon secondary to systemic sclerosis. Mavrikakis ME; Lekakis JP; Papamichael CM; Stamatelopoulos KS; Kostopoulos ChC; Stamatelopoulos SF Int J Vitam Nutr Res; 2003 Feb; 73(1):3-7. PubMed ID: 12690904 [TBL] [Abstract][Full Text] [Related]
22. Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril. Sfikakis PP; Kyriakidis MK; Vergos CG; Vyssoulis GP; Psarros TK; Kyriakidis CA; Mavrikakis ME; Sfikakis PP; Toutouzas PK Am J Med; 1991 May; 90(5):541-6. PubMed ID: 2029011 [TBL] [Abstract][Full Text] [Related]
23. Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis. Ellis WW; Baer AN; Robertson RM; Pincus T; Kronenberg MW Am J Med; 1986 Mar; 80(3):385-92. PubMed ID: 3953616 [TBL] [Abstract][Full Text] [Related]
24. [Use of defibrotide in the treatment of Raynaud's phenomenon associated with progressive systemic sclerosis or essential mixed cryoglobulinemia]. Ranieri G; De Mitrio V; Petronelli M; Ancona A; Dammacco F Clin Ter; 1988 Sep; 126(5):335-43. PubMed ID: 2973963 [No Abstract] [Full Text] [Related]
25. Thermographic and symptomatic effect of a single dose of sildenafil citrate on Raynaud's phenomenon in patients with systemic sclerosis: a potential treatment. Kumar N; Griffiths B; Allen J J Rheumatol; 2006 Sep; 33(9):1918-9. PubMed ID: 16960964 [No Abstract] [Full Text] [Related]
27. Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol. Milio G; Corrado E; Genova C; Amato C; Raimondi F; Almasio PL; Novo S Rheumatology (Oxford); 2006 Aug; 45(8):999-1004. PubMed ID: 16484290 [TBL] [Abstract][Full Text] [Related]
28. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma. Colakoğlu M; Cobankara V; Akpolat T Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574 [TBL] [Abstract][Full Text] [Related]
29. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis. Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043 [TBL] [Abstract][Full Text] [Related]
30. Whole blood platelet aggregation and coagulation factors in patients with systemic sclerosis. Goodfield MJ; Orchard MA; Rowell NR Br J Haematol; 1993 Aug; 84(4):675-80. PubMed ID: 8217827 [TBL] [Abstract][Full Text] [Related]
31. Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud's phenomenon and systemic sclerosis: a randomized, open, single-center study. Kawald A; Burmester GR; Huscher D; Sunderkötter C; Riemekasten G J Rheumatol; 2008 Sep; 35(9):1830-7. PubMed ID: 18634152 [TBL] [Abstract][Full Text] [Related]
33. [Comparative study of misoprostol and nifedipine in the treatment of Raynaud's phenomenon secondary to systemic diseases. Hemodynamic assessment with Doppler duplex]. Varela-Aguilar JM; Sánchez-Román J; Talegón Meléndez A; Castillo Palma MJ Rev Clin Esp; 1997 Feb; 197(2):77-83. PubMed ID: 9213861 [TBL] [Abstract][Full Text] [Related]
34. The pharmacological effects of cicaprost, an oral prostacyclin analogue, in patients with Raynaud's syndrome secondary to systemic sclerosis--a preliminary study. Lau CS; McLaren M; Saniabadi A; Scott N; Belch JJ Clin Exp Rheumatol; 1991; 9(3):271-3. PubMed ID: 1879086 [TBL] [Abstract][Full Text] [Related]
35. [Controlled study of nifedipine in the treatment of Raynaud's phenomenon]. Kahan A; Weber S; Amor B; Saporta L; Hodara M; Degeorges M Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):337-43. PubMed ID: 6285445 [TBL] [Abstract][Full Text] [Related]
36. [A case of systemic sclerosis in childhood complicated by severe digital ulcers]. Falcini F; Volpi M; Pierattelli M; Taccetti G; Pratesi G; Matucci Cerinich M Pediatr Med Chir; 1984; 6(5):703-7. PubMed ID: 6535137 [TBL] [Abstract][Full Text] [Related]
37. Platelet serotonin in systemic sclerosis. Klimiuk PS; Grennan A; Weinkove C; Jayson MI Ann Rheum Dis; 1989 Jul; 48(7):586-9. PubMed ID: 2774700 [TBL] [Abstract][Full Text] [Related]
38. Raynaud's phenomenon and systemic sclerosis. Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438 [TBL] [Abstract][Full Text] [Related]
39. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis. Gore J; Silver R Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356 [No Abstract] [Full Text] [Related]
40. [Corinfar in the treatment of Raynaud's syndrome in systemic scleroderma (preliminary results)]. Shcherbakov AB; Guseva NG; Mach ES Ter Arkh; 1985; 57(5):141-4. PubMed ID: 4023933 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]